Corporate News     22-Aug-23
Marksans Pharma receives USFDA approval for Guaifenesin ER Tablets
Marksans Pharma announced that it has received final approval from the US Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC) The Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC) are bioequivalent to the reference listed drug (RLD), Mucinex Extended-Release Tablets, 600 mg and 1200 mg, of RB Health (US) LLC.

Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. The company expects to launch the product immediately.

Previous News
  Marksans Pharma AGM scheduled
 ( Corporate News - 04-Aug-23   11:09 )
  Marksans Pharma receives affirmation in credit ratings
 ( Corporate News - 07-Feb-23   12:46 )
  Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   12:11 )
  Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant
 ( Hot Pursuit - 18-Apr-24   11:52 )
  Marksans Pharma spurts on buying Tevapharm's bulk formulations biz
 ( Hot Pursuit - 12-Oct-22   09:36 )
  Marksans Pharma standalone net profit declines 33.55% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:23 )
  Marksans Pharma jumps on raising funds via conversion of warrants
 ( Hot Pursuit - 20-Jan-23   11:03 )
  Marksans Pharma to hold board meeting
 ( Corporate News - 02-Nov-19   18:59 )
  Marksans Pharma receives USFDA approval for Pregabalin Capsules
 ( Corporate News - 21-Jul-22   13:21 )
  Marksans Pharma standalone net profit declines 88.78% in the March 2017 quarter
 ( Results - Announcements 29-May-17   17:06 )
  Godawari Power & Ispat Ltd leads losers in 'A' group
 ( Hot Pursuit - 31-Mar-23   15:01 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top